Hosted on MSN11mon
Novo Nordisk's unique structure gives it an extra edge — and riskThe blockbuster success of GLP-1 drugs has put Novo Nordisk — and the 100-year-old company's unique structure — in the spotlight. On Monday, the pharmaceutical giant was named Yahoo Finance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback